The Effect of Ketamine on the Length of Hospital Stay of Patients Hospitalized With Suicidal Ideation.

Brief Summary

This study will evaluate the effect of ketamine on the treatment of patients hospitalized with suicidal thoughts. Half of the patients will receive one dose of ketamine in the vein. The other half will receive a placebo. Because we think that ketamine will improve depression and suicidal thoughts, we expect that patients who receive ketamine will require less time in the hospital than patients who receive placebo.

Intervention / Treatment

  • Drug: Ketamine
  • Drug: Normal saline

Condition or Disease

  • Suicidal Ideation

Phase

Study Design

Study type: Interventional
Status: Terminated
Study results: Has Results
Age: 18 Years to 64 Years   (Adult)
Enrollment: 4 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Mar 02, 2017
Primary Completion: May 19, 2017
Completion Date: May 19, 2017
Study First Posted: Dec 20, 2016
Results First Posted: Apr 29, 2020
Last Updated: Jun 02, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Patients admitted to UMMC's psychiatry inpatient unit with suicidal thoughts will be given the opportunity to participate in the study. Those patients who consent to participate, after being informed about the study and its risks, will be randomized to receive an IV infusion of either saline or ketamine 0.5 mg/kg. The infusion will be given within 24 hours of arriving on the psychiatry inpatient unit. We will record the dates and times that the patient was admitted to and discharged from the psychiatric inpatient unit. At completion of the study, we will compare the average length of stay, defined as date and time of discharge minus date of time of admission, of the group that received ketamine to the average length of stay of the group that received placebo.

Eligibility Criteria

Sex: All
Minimum Age: 18
Maximum Age: 64

More Details

NCT Number: NCT02997722
Other IDs: 2016-0107
Study URL: https://ClinicalTrials.gov/show/NCT02997722
Last updated: Jun 17, 2022